Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 21, 2020 08:55 ET | Source: SPR Therapeutics, Inc.

Study of Sprint Peripheral Nerve Stimulation System Demonstrates 12 Months of Low Back Pain Relief Following 60-Day Treatment

CLEVELAND, Jan. 21, 2020 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc., a leader in neurostimulation technology for pain management, today announced publication of a prospective case series regarding...
December 10, 2019 08:29 ET | Source: SPR Therapeutics, Inc.

Study Demonstrates 12-Month Relief of Post-Amputation Pain Following Treatment With SPRINT PNS System

CLEVELAND, Dec. 10, 2019 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc., a leader in neurostimulation technology for pain management, today announced publication of 12-month follow up results of its...
December 04, 2019 08:30 ET | Source: SPR Therapeutics, Inc.

SPR Therapeutics Announces 1000th Sprint PNS Procedure

CLEVELAND, Dec. 04, 2019 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc., a leader in neurostimulation technology for pain management, announced today the successful commercial placement of its 1000th...
August 21, 2019 08:30 ET | Source: SPR Therapeutics, Inc.

SPR Therapeutics’ SPRINT Peripheral Nerve Stimulation System Significantly Reduces Opioid Use in Patients with Low Back Pain, Interim Data Show

CLEVELAND, Ohio and KISSIMMEE, Florida, Aug. 21, 2019 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc., a leader in neurostimulation technology for pain management, presented interim results today on the...
April 08, 2019 13:39 ET | Source: SPR Therapeutics, Inc.

Study of SPR Therapeutics’ Peripheral Nerve Stimulation System Demonstrates Significant and Sustained Relief of Post-Amputation Pain

CLEVELAND, April 08, 2019 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc., a leader in neurostimulation technology for pain management, today announced the results of a study of its SPRINT® Peripheral...
January 15, 2019 10:00 ET | Source: SPR Therapeutics, Inc.

SPR Therapeutics Names Dr. Peter Staats as Chief Medical Advisor

CLEVELAND, Jan. 15, 2019 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc., a leader in neurostimulation technology for pain management, today announced that Peter Staats, MD, MBA, has been named Chief...
November 15, 2018 08:00 ET | Source: SPR Therapeutics, Inc.

SPR Therapeutics Announces First Use of SPRINT endura Peripheral Nerve Stimulation System to treat Complex Regional Pain Syndrome

SPRINT System is the least invasive PNS device for CRPS CLEVELAND, Nov. 15, 2018 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc., a leader in neurostimulation technology for pain management, today...
October 02, 2018 10:30 ET | Source: SPR Therapeutics, Inc.

SPR Therapeutics Awarded $10M From U.S. Department of Defense

CLEVELAND, Oct. 02, 2018 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc., a leader in neurostimulation technology for pain management, has been awarded two new grants and one new contract from the U.S....
September 25, 2018 10:10 ET | Source: SPR Therapeutics, Inc.

SPR Therapeutics Announces First Use of SPRINT extensa Dual-lead Peripheral Nerve Stimulation System to Treat Low Back Pain

CLEVELAND, Sept. 25, 2018 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc., a leader in neurostimulation technology for pain management, today announced that Christopher Gilmore, MD of Carolinas Pain...
August 16, 2018 08:30 ET | Source: SPR Therapeutics, Inc.

FDA Clears SPR Therapeutics’ Non-opioid SPRINT endura and extensa Peripheral Nerve Stimulation Systems for Pain Management

SPRINT® is the First and Only Dual Lead Capable PNS Platform Company also provides first look at 12-month durability outcomes following 60-day SPRINT therapy CLEVELAND, Aug. 16, 2018 (GLOBE...